Retroperitoneal Hemorrhage from Adrenocortical Carcinoma as a Poor Prognostic Factor
Journal Title: International Journal of Biomedical Science (IJBS) - Year 2008, Vol 4, Issue 1
Abstract
In most patients, adrenocortical carcinoma is diagnosed at an advanced stage of the disease. A sudden retroperitoneal hemorrhage may sometimes be the first symptom of the adrenal cancer. We describe four patients with adrenocortical carcinoma diagnosed during a retroperitoneal hemorrhage. A clinical analysis suggests that such a complication is a poor prognostic factor. How to cite this article: Int. J. Biomed. Sci. 2008; 4(1):78-81 For full text article or PDF file, visit: [url=http://www.ijbs.org]www.ijbs.org[/url]
Authors and Affiliations
Wojciech Zgliczynski, Anna Kasperlik-Zaluska, Rafal Slapa, Andrzej Cichocki
Free Radicals, Antioxidants in Disease and Health
Free radicals and oxidants play a dual role as both toxic and beneficial compounds, since they can be either harmful or helpful to the body. They are produced either from normal cell metabolisms in situ or from external...
Investigating the Icr Effect in a Zhadin’s Cell
Investigations into the ion cyclotronic resonance (ICR) in living matter confront the so called Zhadin effect (12), whose explanation is not fully achieved. Several attempts have been done to explain this phenomenon, the...
Relationship between NK Cell Activation and Clinical Response in Rheumatoid Arthritis Treated with Rituximab
Introduction: We investigated the relationship between the anti CD20 therapy and the NK cell phenotype in patients with Rheumatoid Arthritis (RA). Methods: patients with seropositive RA according to the ACR criteria tha...
Spectrophotometric Determination of Risedronate in Pharmaceutical Formulations via Complex Formation with Cu (II) Ions: Application to Content Uniformity Testing
A simple, sensitive, rapid and accurate spectrophotometric method was developed for the determination of risedronate, a bisphosphonate drug important for the treatment of a variety of bone diseases, in raw material and p...
An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan, Improves Insulin Resistance in KK-Ay Diabetic Mice
Metabolic syndrome is strongly associated with insulin resistance and consists of a constellation of factors such as hypertension and hyperlipidemia that raise the risk for cardiovascular diseases and diabetes mellitus....